Close
CDMO Safety Testing 2026
Novotech

Inizio strengths senior team with DE&I appointment

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition

Angelini Pharma has finalized a definitive agreement to acquire...

Are Glutathione Injections in NYC Worth It? A Complete Guide

When whatever you do to your skin makes it...
- Advertisement -

Inizio a global strategic partner for health and life sciences with a full suite of advisory, medical, marketing, communications, and patient and stakeholder engagement services, has strengthened its senior leadership team with the appointment of Stefanie Christmas as its new Global Head of Diversity, Equity & Inclusion (DE&I).

In her new role, Stefanie will be responsible for developing an organization-wide DE&I strategy, and working with individual Business Unit leaders to deliver operational alignment and accountability, as part of Inizioโ€™s commitment to DE&I.

Stefanie is a highly experienced professional with a breadth of expertise in strategic planning and organizational effectiveness, spanning the public and private sectors and multiple industries.

She joins the Inizio executive team from Vynamic (an Inizio Advisory company), where she made her mark by founding Vynamicโ€™s DE&I efforts in 2016, developing an organizational vision and mission to align with its values and culture. In addition to this achievement, Stefanie co-developed Vynamicโ€™s DE&I Consulting Service to help their clients define, develop and operationalize their DE&I strategy.

Commenting on her appointment Stefanie said, โ€œHaving previously worked for Vynamic for seven and a half years, I am looking forward to taking up a new challenge working as part of Inizioโ€™s extended executive team. During my time with the company, Iโ€™ve worked with some phenomenal companies across the biotech, biopharma, and pharmaceutical sectors. Having worked transformational initiatives to embed DE&I in organizations, I canโ€™t wait to get started and make my mark in my new role.โ€

Inizioโ€™s Chief Executive Officer Paul Taaffe added, โ€œDiversity, Equity, and Inclusion are at the heart of a central Inizio value; we empower everyone. We strive to be a business that our team is proud to be a part of.

โ€œThroughout her career, Stefanie has been highly successful in helping organizations take their DE&I offering to the next level, which will be a big asset at Inizio. Itโ€™s also great to appoint Stefanie from within the Inizio family, showcasing the opportunities across the group when it comes to our team’s career development. I wish Stefanie the best of luck in her new role and Iโ€™m excited to see what the future holdsโ€.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition

Angelini Pharma has finalized a definitive agreement to acquire...

Are Glutathione Injections in NYC Worth It? A Complete Guide

When whatever you do to your skin makes it...

Fujifilm Advances Drug Discovery with New Cyclic Peptide Screening Platform

FUJIFILM Corporation has developed a new screening methodology aimed...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป